Cristina Griffin Joins Or-Genix Therapeutics as Chief Business Officer
11 July 2019 - - US-based Or-Genix Therapeutics, Inc. has hired Cristina Griffin has joined as chief business officer, a newly created position, the company said.
She joins from Cantabria Labs in Madrid, Spain where she held the role of Managing director of Corporate Development for 15 years.
Cristina has more than 20 years of experience as a global strategist and corporate development executive. Her career has extended across Europe, North America, and Latin America where she has directed over twenty mergers and acquisitions projects with a focus in pharmaceuticals, biotech, aesthetic dermatology and consumer healthcare.
Cristina's vast experience includes corporate strategy, equity financing, high margin product innovation, global branding and strategic alliance building.
Cristina received her BA from the University of Wisconsin, her MA from St. John's College, Maryland and her MBA in Global Strategic Management from Macquarie Graduate School Management, NSW, Australia.
Or-Genix is a Worcester, MA based research and development company focused on safe and effective topical, rapidly biodegradable pharmaceuticals and cosmeceuticals for both the professional and non-professional woman's healthcare and dermatology markets.